BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2449381)

  • 1. Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium.
    Herbort CP; Zografos L; Zwingli M; Schoeneich M
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(1):22-6. PubMed ID: 2449381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study.
    Soong HK; Martin NF; Wagoner MD; Alfonso E; Mandelbaum SH; Laibson PR; Smith RE; Udell I
    Ophthalmology; 1988 Oct; 95(10):1442-6. PubMed ID: 3067180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical retinoic acid treatment of drug-induced pseudopemphigoid.
    Herbort CP; Matter M; Uffer S
    Ophthalmologica; 1986; 193(1-2):27-33. PubMed ID: 3547230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical retinoic acid therapy for disorders of the outer eye.
    Wright P
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 8)():869-74. PubMed ID: 3868880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of corneal xerophthalmia in rabbits with micromolar doses of topical retinoic acid.
    Ubels JL; Rismondo V; Edelhauser HF
    Curr Eye Res; 1987 May; 6(5):735-7. PubMed ID: 3595183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of transglutaminase 1 and keratinization-related proteins in conjunctiva in severe ocular surface disease.
    Nakamura T; Nishida K; Dota A; Matsuki M; Yamanishi K; Kinoshita S
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):549-56. PubMed ID: 11222510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
    Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
    Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity of N-(4-hydroxyphenyl) retinamide-O-glucuronide in corneal and conjunctival cells of rabbits and humans.
    Ubels JL; Dennis MH; Mitchell JH; Wiley LA; Curley RW
    Curr Eye Res; 1995 Dec; 14(12):1115-24. PubMed ID: 8974841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tretinoin treatment for severe dry-eye disorders.
    Tseng SC
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):860-6. PubMed ID: 3534023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea.
    Yeatts RP; Ford JG; Stanton CA; Reed JW
    Ophthalmology; 1995 Sep; 102(9):1338-44. PubMed ID: 9097771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular surface keratinization as a predictor of response to topical retinoic acid therapy.
    Herbort CP; Weissman SS; Ostler HB; Cevallos A; Char DH
    Arch Ophthalmol; 1989 Sep; 107(9):1275-6. PubMed ID: 2476978
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical retinoid treatment for dry eye disorders.
    Tseng SC
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 4)():489-95. PubMed ID: 3862277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular surface disorders and tear function changes in patients with chronic renal failure.
    Ozdemir M; Bakaris S; Ozdemir G; Buyukbese MA; Cetinkaya A
    Can J Ophthalmol; 2004 Aug; 39(5):526-32. PubMed ID: 15491038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change of paracellular permeability of ocular surface epithelium by vitamin A deficiency.
    Huang AJ; Tseng SC; Kenyon KR
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):633-9. PubMed ID: 1900498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vivo confocal microscopy and ocular surface diseases: anatomical-clinical correlations].
    De Nicola R; Labbé A; Amar N; Dupas B; Baudouin C
    J Fr Ophtalmol; 2005 Sep; 28(7):691-8. PubMed ID: 16208218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
    Yeatts RP; Engelbrecht NE; Curry CD; Ford JG; Walter KA
    Ophthalmology; 2000 Dec; 107(12):2190-5. PubMed ID: 11097594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Zaki AA; Farid SF
    Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of involucrin by ocular surface epithelia of patients with benign and malignant disorders.
    Saika S; Minamide A; Tanaka T; Miyamoto T; Okada Y; Kawashima Y; Ohnishi Y; Ooshima A; Kao WW
    Curr Eye Res; 2000 Nov; 21(5):877-85. PubMed ID: 11262609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.